Cargando…
Do proton pump inhibitors increase mortality? A systematic review and in‐depth analysis of the evidence
Proton pump inhibitors (PPIs) were primarily approved for short‐term use (2 to 8 weeks). However, PPI use continues to expand. Widely believed to be safe, we reviewed emerging evidence on increased mortality with PPI long‐term use. Our 2016 systematic PPI drug class review found that mortality was n...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525804/ https://www.ncbi.nlm.nih.gov/pubmed/32996701 http://dx.doi.org/10.1002/prp2.651 |